Quick answer
EHL BIO maintains a robust partner network consisting of leading hospitals in South Korea and Thailand, spanning specialized clinics, medical universities, and treatment centers to support high-quality medical services and clinical research based on EHL team assessments.
Key takeaways
- Extensive network of leading hospitals in Korea and Thailand.
- Partnerships with top medical universities including Yonsei, Chungnam, and Dankook Universities.
- Collaboration with top-tier surgical and aesthetic clinics like JK, id, and EU.
- Expanded service base to cover regional clients.
Foundation of Partnerships with Leading South Korean Medical Institutions
EHL BIO believes that success in regenerative medicine stems from the exchange of knowledge and technology. We have established strong alliances with leading surgical hospitals and specialized clinics in South Korea, including Yonsei Jayunmi, Ohkims, JK, id, and EU Plastic Surgery. These collaborations ensure the efficient isolation and application of adipose-derived stem cells.
Furthermore, we partner with premium clinics such as Leoncell and Well-Aging to integrate anti-aging and regenerative health approaches into clinical treatments, focusing on patients' quality of life. Managed by expert medical teams, these efforts involve coordination between EHL BIO's research institutes and our medical partners.
Academic and Research Collaboration at the University Level
To ensure cell therapy technologies are developed according to scientific standards, EHL BIO has signed Memorandums of Understanding (MOU) with several top university hospitals for joint R&D, including Gangnam Severance (Yonsei University), Chonnam National University Hospital, and Wonkwang University Hospital.
These collaborations focus on clinical trials in advanced regenerative medicine for chronic and neurological conditions. Combining clinical experience from university hospitals with our GMP-standard cell culture technology drives innovations into accessible care standards.
Connecting biotech innovation with a leading medical network is the heart of achieving recovery goals and quality of life.
Expanding the Regional Medical Service Network
EHL BIO aims for leadership by expanding its network to international medical partners, particularly establishing strong collaborations in Thailand. This ensures clients can conveniently access EHL BIO’s advanced technology with systematic care under improved quality of life standards based on EHL team assessments.
Service Process via EHL Thailand Network
For clients from Thailand, EHL Thailand provides a comprehensive Thai coordination team. The process begins with an online consultation, followed by medical document evaluation to create a personalized travel and recovery plan.
The core steps include health screening and cell collection at the EHL Cell Clinic in Seoul. Cells are then cultured in our state-of-the-art GMP facility before administration according to the plan. Follow-up systems are in place after returning to Thailand to ensure continuity of quality of life and recovery goals.
Frequently asked questions
In which countries does EHL BIO have partners?
EHL BIO's network covers South Korea and Thailand.
Is the care standard consistent across the partner network?
All cell culture processes are conducted at EHL BIO's GMP facility, and managed by expert medical teams following uniform standards.
What are the goals for recovery and quality of life for patients?
EHL BIO focuses on physical recovery and enhancing the patient's quality of life, based on EHL team assessments, to help patients return to their daily lives optimally.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.
